April Bell

603 total citations
10 papers, 236 citations indexed

About

April Bell is a scholar working on Molecular Biology, Neurology and Biological Psychiatry. According to data from OpenAlex, April Bell has authored 10 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Neurology and 3 papers in Biological Psychiatry. Recurrent topics in April Bell's work include Tryptophan and brain disorders (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Stress Responses and Cortisol (2 papers). April Bell is often cited by papers focused on Tryptophan and brain disorders (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Stress Responses and Cortisol (2 papers). April Bell collaborates with scholars based in United States and Italy. April Bell's co-authors include Derek A. Wainwright, Erik Ladomersky, Kristen L. Lauing, Lijie Zhai, Gary E. Schiltz, Robert H. McCusker, Eugene Wyatt, Lynn Doglio, Bin Zhang and Jeffrey A. Sosman and has published in prestigious journals such as The Journal of Immunology, Methods in enzymology on CD-ROM/Methods in enzymology and Journal of Lipid Research.

In The Last Decade

April Bell

8 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
April Bell United States 5 103 70 60 54 25 10 236
Lara Stepan United States 6 50 0.5× 95 1.4× 167 2.8× 77 1.4× 35 1.4× 7 318
Lloyd Bod France 8 141 1.4× 55 0.8× 74 1.2× 20 0.4× 6 0.2× 10 247
Cheng-Ying Wu United States 5 113 1.1× 170 2.4× 74 1.2× 39 0.7× 13 0.5× 7 315
Annette E. Patterson Canada 3 147 1.4× 110 1.6× 81 1.4× 22 0.4× 4 0.2× 5 302
Silvia Martín Spain 4 68 0.7× 40 0.6× 37 0.6× 18 0.3× 5 0.2× 8 157
Ivana Apicella United States 10 57 0.6× 144 2.1× 29 0.5× 12 0.2× 5 0.2× 16 259
Alan Kadison United States 11 105 1.0× 142 2.0× 110 1.8× 17 0.3× 8 0.3× 18 380
Truong San Phan Germany 9 89 0.9× 72 1.0× 57 0.9× 6 0.1× 7 0.3× 12 230
Marisa K. Kilgour Canada 8 114 1.1× 63 0.9× 118 2.0× 5 0.1× 3 0.1× 9 268
Laëtitia Douguet France 10 152 1.5× 95 1.4× 96 1.6× 14 0.3× 1 0.0× 13 304

Countries citing papers authored by April Bell

Since Specialization
Citations

This map shows the geographic impact of April Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by April Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites April Bell more than expected).

Fields of papers citing papers by April Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by April Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by April Bell. The network helps show where April Bell may publish in the future.

Co-authorship network of co-authors of April Bell

This figure shows the co-authorship network connecting the top 25 collaborators of April Bell. A scholar is included among the top collaborators of April Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with April Bell. April Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kim, Miri, April Bell, Lijie Zhai, et al.. (2022). A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer. Brain Behavior & Immunity - Health. 21. 100449–100449. 4 indexed citations
2.
Bommi, Prashant, Lijie Zhai, April Bell, et al.. (2022). CNSC-27. AN IDO-PROTAC HIGHLIGHTS A NOVEL TRYPTOPHAN METABOLISM- INDEPENDENT ROLE FOR IMMUNOSUPPRESSIVE IDO IN HUMAN GLIOBLASTOMA. Neuro-Oncology. 24(Supplement_7). vii28–vii28. 1 indexed citations
3.
Zhai, Lijie, April Bell, Erik Ladomersky, et al.. (2020). Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies. Frontiers in Immunology. 11. 1185–1185. 155 indexed citations
4.
Ladomersky, Erik, Lijie Zhai, Lakshmi Reddy Bollu, et al.. (2020). IMMU-40. IMPROVING OUTCOMES IN OLDER ADULTS WITH GLIOBLASTOMA BY REVERSING AGE-RELATED CHANGES OF THE CENTRAL NERVOUS SYSTEM. Neuro-Oncology. 22(Supplement_2). ii113–ii113.
5.
Bollu, Lakshmi Reddy, Derek A. Wainwright, Lijie Zhai, et al.. (2020). DDRE-09. DEVELOPING IDO-PROTACS TO IMPROVE IMMUNOTHERAPEUTIC EFFICACY IN PATIENTS WITH GLIOBLASTOMA. Neuro-Oncology. 22(Supplement_2). ii63–ii63. 1 indexed citations
6.
Zhai, Lijie, et al.. (2019). Quantification of IDO1 enzyme activity in normal and malignant tissues. Methods in enzymology on CD-ROM/Methods in enzymology. 629. 235–256. 15 indexed citations
7.
8.
Zhai, Lijie, April Bell, Jun Qian, et al.. (2019). Tumor cell IDO1 increases intratumoral immunosuppressive Tregs independent of enzyme activity. The Journal of Immunology. 202(1_Supplement). 137.2–137.2.
9.
Gabrielli, Sara, Mengxi Sun, April Bell, et al.. (2017). Murine thymic NK cells are distinct from ILC1s and have unique transcription factor requirements. European Journal of Immunology. 47(5). 800–805. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026